In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-7 of 7 for your search:
Drug:  ranpirnase
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Completed
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALFACELL-P30-300, NCI-V95-0752

2.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALFACELL-P30-303, NCI-V96-0938

3.

Phase: Phase III
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALFACELL-P30-302, NCI-V97-1273, NCT00003034

4.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: ALFACELL-P30-400, NCI-V96-0937

5.

Phase: Phase II
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor: Other
Protocol IDs: TCSC-P-30-P/PHII, NCI-V92-0008

6.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P30-800, NCT01184287

7.

Phase: Phase I
Type: Treatment
Status: Closed
Age: 21 and over
Sponsor:
Protocol IDs: TCSC-P-30-PROTEIN, NCI-V90-0188
New Search